Annovis Bio, Inc. Contracts & Agreements
31 Contracts & Agreements
- Business Finance (12 contracts)
- Business Operations (2)
- Human Resources (8)
- Intellectual Property (3)
- Uncategorized (6)
- Distribution Agreement, dated December 11, 2024, by and between Annovis Bio, Inc. and Oppenheimer & Co. Inc (Filed With SEC on December 11, 2024)
- Separation Agreement and General Release, dated April 30, 2024, by and between the Company and Henry Hagopian, III (Filed With SEC on May 1, 2024)
- Registration Rights Agreement dated as of April 25, 2024 between Annovis Bio, Inc. and the ELOC Purchaser Capital Partners, LLC (Filed With SEC on April 26, 2024)
- Common Stock Purchase Agreement dated as of April 25, 2024 between Annovis Bio, Inc. and the ELOC Purchaser Capital Partners, LLC (Filed With SEC on April 26, 2024)
- NONQUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on March 29, 2024)
- Description of Registrants Securities (Filed With SEC on March 29, 2024)
- Securities Purchase Agreement, dated March 21, 2024 (Filed With SEC on March 21, 2024)
- Securities Purchase Agreement, dated March 15, 2024 (Filed With SEC on March 15, 2024)
- Form of Warrant (Filed With SEC on November 1, 2023)
- Underwriting Agreement, dated October 31, 2023, between Annovis Bio, Inc. and Canaccord Genuity LLC (Filed With SEC on November 1, 2023)
- At-the-Market Equity Offering Sales Agreement, dated March 31, 2023, by and among Annovis Bio, Inc., BofA Securities, Inc. and ThinkEquity LLC (Filed With SEC on April 3, 2023)
- Form of Stock Option Award Agreement for the Annovis Bio, Inc. 2019 Equity Incentive Plan (Filed With SEC on March 31, 2023)
- Separation Agreement and General Release, dated September 9, 2022, by and between the Company and Jeffrey B. McGroarty (Filed With SEC on September 12, 2022)
- Offer Letter, dated August 29, 2022, by and between the Company and Henry Hagopian III (Filed With SEC on August 30, 2022)
- Underwriting Agreement, dated as of May 23, 2021, between Annovis Bio, Inc. and ThinkEqutiy, a division of Fordham Financial Management, Inc (Filed With SEC on May 24, 2021)
- Manufacturing Agreement, dated March 9, 2021, by and between the Registrant and Wilmington PharmaTech Company, LLC (Filed With SEC on May 6, 2021)
- Employment Agreement dated as of March 24, 2020 between the Registrant and Jeffrey McGroarty (Filed With SEC on March 25, 2020)
- Second Amended and Restated Employment Agreement dated as of March 24, 2020 between the Registrant and Maria Maccecchini (Filed With SEC on March 25, 2020)
- Description of Registrants Securities (Filed With SEC on March 25, 2020)
- Form of Warrant to purchase common stock issued to ThinkEquity, a division of Fordham Financial Management, Inc. in connection with the closing of the IPO (Filed With SEC on March 25, 2020)
- Form of Underwriting Agreement (Filed With SEC on January 24, 2020)
- Form of Underwriting Agreement (Filed With SEC on January 21, 2020)
- Specimen Certificate evidencing shares of the Registrant's common stock (Filed With SEC on September 20, 2019)
- Registration Rights Agreement dated as of December 19, 2014 among the Registrant and the signatories thereto (Filed With SEC on August 8, 2019)
- Form of Annovis Bio, Inc., 2019 Equity Incentive Plan, to be in effect upon completion of this offering (Filed With SEC on August 8, 2019)
- Investigator-Initiated Clinical Trial Agreement dated June 27, 2016 between The Regents of the University of California and the Registrant (Filed With SEC on July 3, 2019)
- License Agreement Amendment No. 2 effective as of May 2, 2012 between Raptor Therapeutics and the Registrant (Filed With SEC on July 3, 2019)
- License Agreement Amendment dated November 29, 2011 between Raptor Therapeutics, Inc. and the Registrant (Filed With SEC on July 3, 2019)
- License Agreement dated as of November 10, 2008 between TorreyPines Therapeutics, Inc. and the Registrant (Filed With SEC on July 3, 2019)
- Annovis Bio, Inc. 2018 Equity Incentive Plan (Filed With SEC on July 3, 2019)
- Amended and Restated Employment Agreement dated as of May 10, 2019 between the Registrant and Maria Maccecchini (Filed With SEC on July 3, 2019)
